Eterna Therapeutics Inc. (ERNA)
NASDAQ: ERNA · Real-Time Price · USD
1.070
+0.030 (2.88%)
At close: Nov 4, 2024, 4:00 PM
1.120
+0.050 (4.66%)
After-hours: Nov 4, 2024, 4:02 PM EST
Eterna Therapeutics Employees
Eterna Therapeutics had 8 employees as of December 31, 2023. The number of employees decreased by 1 or -11.11% compared to the previous year.
Employees
8
Change (1Y)
-1
Growth (1Y)
-11.11%
Revenue / Employee
$20,250
Profits / Employee
-$2,992,000
Market Cap
5.79M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 8 | -1 | -11.11% |
| Dec 31, 2022 | 9 | -1 | -10.00% |
| Dec 31, 2021 | 10 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Mainz Biomed | 71 |
| Kindly MD | 65 |
| Sunshine Biopharma | 44 |
| Purple Biotech | 20 |
| Aethlon Medical | 14 |
| CNS Pharmaceuticals | 5 |
| Creative Medical Technology Holdings | 4 |
| Mangoceuticals | 3 |
ERNA News
- 5 days ago - Eterna Therapeutics Completes Strategic Financial Restructuring with the Aim to Accelerate its Developmental Activities and Long-Term Success - GlobeNewsWire
- 18 days ago - Eterna Therapeutics and Factor Bioscience Announce Exclusive License and Collaboration Agreement to Accelerate Cell Therapy Development for Oncology, Autoimmune, and Rare Diseases - GlobeNewsWire
- 6 months ago - Eterna Therapeutics to Present at the ASGCT 27th Annual Meeting on Development of Beta 2 Microglobulin-Knockout (B2M-KO) iMSC Line with Enhanced Immunosuppressive Activity and Stealthing Features that May Further Augment the Therapeutic Potential of MSCs - GlobeNewsWire
- 6 months ago - Eterna Therapeutics Announces Appointment of Mahendra Rao, PhD, to its Scientific Advisory Board - GlobeNewsWire
- 9 months ago - Eterna Therapeutics Announces the Appointment of Peter Cicala, JD, to its Board of Directors - GlobeNewsWire
- 10 months ago - Eterna Therapeutics Grants New President and CEO Sanjeev Luther Inducement Award Under Nasdaq Listing Rule 5635 (c)(4) - GlobeNewsWire
- 11 months ago - Eterna Therapeutics Names Sanjeev Luther as President and Chief Executive Officer - GlobeNewsWire
- 11 months ago - Eterna Therapeutics Announces $9.2 Million Convertible Debt and Warrant Financing - GlobeNewsWire